Calendar

Week of Sep 22, 2025

Sep 24, 2025grant340d agoVENA VITALS, INC. — Continuous Non-Invasive Blood Pressure during Sleep as a Cardiovascular Bioma...

HL grant. $306,872. PI: Joshua Kim

full page →nih reporter ↗

Sep 24, 2025grant340d agoLEIDOS BIOMEDICAL RESEARCH, INC. — FY25 TO-H W3F1 RENOVATIONS

CA grant. $1,856,809. PI: lynn briscoe

full page →nih reporter ↗

Sep 25, 2025approval339d agoITOVEBI (INAVOLISIB) — FDA approvalinavolisib

Sponsor: GENENTECH INC. Form: TABLET. Route: ORAL

full page →inavolisib →fda approvals ↗

Sep 25, 2025approval339d agoALYFTREK (DEUTIVACAFTOR) — FDA approval(deutivacaftor + tezacaftor + vanzacaftor calcium)

Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

full page →(deutivacaftor + tezacaftor + vanzacaftor calcium) →fda approvals ↗

Sep 25, 2025approval339d agoTRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approvalTRIKAFTA (COPACKAGED)

Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

full page →TRIKAFTA (COPACKAGED) →fda approvals ↗

Sep 25, 2025approval339d agoTRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approvalTRIKAFTA (COPACKAGED)

Sponsor: VERTEX PHARMS INC. Form: GRANULES. Route: ORAL

full page →TRIKAFTA (COPACKAGED) →fda approvals ↗

Sep 25, 2025approval339d agoORKAMBI (IVACAFTOR) — FDA approval(ivacaftor + lumacaftor)

Sponsor: VERTEX PHARMS INC. Form: GRANULE. Route: ORAL

full page →(ivacaftor + lumacaftor) →fda approvals ↗

Sep 25, 2025approval339d agoKALYDECO (IVACAFTOR) — FDA approvalVertex, Inc.

Sponsor: VERTEX PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Sep 25, 2025approval339d agoKALYDECO (IVACAFTOR) — FDA approvalivacaftor

Sponsor: VERTEX PHARMS INC. Form: GRANULE. Route: ORAL

full page →ivacaftor →fda approvals ↗

Sep 25, 2025approval339d agoORKAMBI (IVACAFTOR) — FDA approval(ivacaftor + lumacaftor)

Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

full page →(ivacaftor + lumacaftor) →fda approvals ↗

Sep 25, 2025approval339d agoSYMDEKO (COPACKAGED) (IVACAFTOR) — FDA approvalivacaftor

Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

full page →ivacaftor →fda approvals ↗

Sep 25, 2025approval339d agoZEPBOUND (TIRZEPATIDE) — FDA approvalZEPBOUND

Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

full page →ZEPBOUND →fda approvals ↗

Sep 25, 2025approval339d agoROBINUL (GLYCOPYRROLATE) — FDA approvalGLYCOPYRROLATE

Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

full page →GLYCOPYRROLATE →fda approvals ↗

Sep 25, 2025approval339d agoMOUNJARO (TIRZEPATIDE) — FDA approvalZEPBOUND

Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

full page →ZEPBOUND →fda approvals ↗

Sep 25, 2025approval339d agoFENTANYL CITRATE — FDA approvalEffentora

Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

full page →Effentora →fda approvals ↗

Sep 25, 2025approval339d agoWEZLANA (USTEKINUMAB-AUUB) — FDA approvalWEZLANA

Sponsor: AMGEN INC. Form: INJECTABLE. Route: INTRAVENOUS, SUBCUTANEOUS

full page →WEZLANA →fda approvals ↗

Sep 25, 2025approval339d agoWEZLANA (USTEKINUMAB-AUUB) — FDA approvalWEZLANA

Sponsor: AMGEN INC. Form: INJECTABLE. Route: INTRAVENOUS, SUBCUTANEOUS

full page →WEZLANA →fda approvals ↗

Sep 25, 2025approval339d agoINLURIYO (IMLUNESTRANT TOSYLATE) — FDA approvalimlunestrant tosylate

Sponsor: ELI LILLY AND CO. Form: TABLET. Route: ORAL

full page →imlunestrant tosylate →fda approvals ↗

Sep 25, 2025approval339d agoCEFUROXIME AXETIL — FDA approvalOrchid Pharma Inc

Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Sep 25, 2025approval339d agoCEFUROXIME AXETIL — FDA approvalOrchid Pharma Inc

Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Sep 25, 2025approval339d agoCEFUROXIME AXETIL — FDA approvalOrchid Pharma Inc

Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Sep 25, 2025approval339d agoPALSONIFY (PALTUSOTINE HYDROCHLORIDE) — FDA approvalpaltusotine hydrochloride

Sponsor: CRINETICS. Form: TABLET. Route: ORAL

full page →paltusotine hydrochloride →fda approvals ↗

Sep 25, 2025approval339d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: AVANTHI INC. Form: CAPSULE. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗

Sep 25, 2025approval339d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: AVANTHI INC. Form: CAPSULE. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗

Sep 25, 2025approval339d agoEVKEEZA (EVINACUMAB-DGNB) — FDA approvalevinacumab

Sponsor: REGENERON PHARMACEUTICALS. Form: SOLUTION. Route: INJECTION

full page →evinacumab →fda approvals ↗

Sep 25, 2025approval339d agoRIVAROXABAN — FDA approvalRIVAROXABAN

Sponsor: LUPIN LTD. Form: FOR SUSPENSION. Route: ORAL

full page →RIVAROXABAN →fda approvals ↗

Sep 25, 2025grant339d agoUNIVERSITY OF ALABAMA AT BIRMINGHAM — iHEAL : Improving HEalth Across the Lifespan

NR grant. $268,612. PI: Marie Anne Bakitas

full page →nih reporter ↗

Sep 25, 2025grant339d agoMIDWESTERN STATE UNIVERSITY — Force Platform Embedded Treadmill with Safety Harness System

AR grant. $230,780. PI: Michael Olson

full page →nih reporter ↗

Sep 25, 2025grant339d agoVIVA VIRAL VACCINES, INC. — Broad-spectrum, multivalent platform for pan-influenza vaccineCurtin University

AI grant. $299,968. PI: David William Buchholz

full page →nih reporter ↗

Sep 25, 2025grant339d agoWEILL MEDICAL COLL OF CORNELL UNIV — Leveraging novel pediatric SHIVs to identify biomarkers of prophylactic effic...

AI grant. $4,686,370. PI: Genevieve Giny Fouda Amou ou

full page →nih reporter ↗

Sep 25, 2025grant339d agoCORNELL UNIVERSITY — An immunomodulatory and vascularized cell delivery device for type 1 diabetes...

DK grant. $509,265. PI: Minseok Lee

full page →nih reporter ↗

Sep 25, 2025grant339d agoVIRGINIA COMMONWEALTH UNIVERSITY — Training CoreVirginia Commonwealth University

AR grant. $298,955. PI: John D Cleary

full page →nih reporter ↗

Sep 25, 2025grant339d agoCLEVELAND CLINIC LERNER COM-CWRU — Alcohol and gut-brain axis and the role of butyrate on neuroinflammation and ...

AA grant. $601,129. PI: Gail Ann Cresci

full page →nih reporter ↗

Sep 25, 2025grant339d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Disability, Disparities and Data Solidarity in Translational Genomic Research...

HG grant. $877,621. PI: Maya Sabatello

full page →nih reporter ↗

Sep 25, 2025grant339d agoBROWN UNIVERSITY — Circuit and molecular mechanisms through which alcohol influences natural reward

AA grant. $2,150,570. PI: Karla R. Kaun

full page →nih reporter ↗

Sep 25, 2025grant339d agoSEATTLE CHILDREN'S HOSPITAL — SERVICE: Newborn genomic sequencing and federally-supported early interventionSeattle Children's Hospital

HG grant. $3,268,197. PI: Kate E. MacDuffie

full page →nih reporter ↗

Sep 25, 2025grant339d agoUNIVERSITY OF PENNSYLVANIA — Cardiovascular Risk Prediction and Reduction in Men with Prostate CancerUniversity of Pennsylvania

HL grant. $716,697. PI: Jinbo Chen

full page →nih reporter ↗

Sep 25, 2025grant339d agoLSU HEALTH SCIENCES CENTER — Geroprotective Precision Medicine Strategies in PWH that Use Alcohol

AA grant. $634,830. PI: Shawn Robert Campagna

full page →nih reporter ↗

Sep 25, 2025grant339d agoUNIVERSITY OF ALABAMA AT BIRMINGHAM — Genotypic and phenotypic approaches to subtype individuals with coronary hear...

HL grant. $158,572. PI: Zhe Wang

full page →nih reporter ↗

Sep 25, 2025grant339d agoUT SOUTHWESTERN MEDICAL CENTER — Circulating metabolites underlying cardiometabolic risk for cardiac dysfuncti...

HL grant. $1,620,016. PI: Amil M Shah

full page →nih reporter ↗

Sep 25, 2025grant339d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — The East Palestine Train Derailment Health Research Program

ES grant. $440,513. PI: Juliane I Beier

full page →nih reporter ↗

Sep 25, 2025grant339d agoYALE UNIVERSITY — The East Palestine Train Derailment Health Research Program

ES grant. $296,221. PI: Michelle L Bell

full page →nih reporter ↗

Sep 25, 2025grant339d agoRHODE ISLAND HOSPITAL — An RCT to Evaluate Treatment Modalities to Halt the Progression of Schistosom...

AI grant. $249,762. PI: JENNIFER F FRIEDMAN

full page →nih reporter ↗

Sep 25, 2025grant339d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Evaluating implementation of the HEARTS hypertension and diabetes primary car...

HL grant. $272,243. PI: David Clifford Flood

full page →nih reporter ↗

Sep 25, 2025grant339d agoUNIVERSITY OF PENNSYLVANIA — Cardiovascular Risk Prediction and Reduction in Men with Prostate CancerUniversity of Pennsylvania

HL grant. $21,775. PI: Jinbo Chen

full page →nih reporter ↗

Sep 25, 2025grant339d agoLOVELACE BIOMEDICAL RESEARCH INSTITUTE — The synchrony study: A randomized controlled trial of music training for chil...

AA grant. $852,356. PI: JULIA MARIE STEPHEN

full page →nih reporter ↗

Sep 25, 2025grant339d agoOLD DOMINION UNIVERSITY — In situ formed microneedle-like depots for spatiotemporally controlled drug d...

EB grant. $208,124. PI: Mohamadmahdi Samandari

full page →nih reporter ↗

Sep 25, 2025grant339d agoWASHINGTON STATE DEPARTMENT OF HEALTH — Washington State Food Safety Surveillance Project

FD grant. $200,000. PI: Vincent W Aoki

full page →nih reporter ↗

Sep 25, 2025grant339d agoALASKA STATE DEPT/ENVIRONMTL CONSERVATN — Alaska Environmental Health Laboratory's continued and enhanced participation...

FD grant. $365,000. PI: PATRYCE D MCKINNEY

full page →nih reporter ↗

Sep 25, 2025grant339d agoMESA SCIENCE ASSOCIATES, INC. — Development of Cobinamide as a Cyanide Antidote: Completion of pre-IND StudiesMesa Science Associates Inc

AI grant. $980,358. PI: GERRY R BOSS

full page →nih reporter ↗

← prev

page 368 of 475

Week of Sep 22, 2025